Ayush Kumar

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Radical Prostatectomy

Prostate Cancer

Locally Advanced

Top Venues

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Mengdie Wang, Christi A Wisniewski, Choua Xiong, Peter Chhoy, Hira Lal Goel, Ayush Kumar, Julie Lihua Zhu, Rui Li, Pamela A St Louis, Lindsay M Ferreira, Hubert Pakula, Zhiwen Xu, Massimo Loda, Zhong Jiang, Michael A Brehm, Arthur M Mercurio
Therapeutic blocking of VEGF binding to neuropilin-2 diminishes PD-L1 expression to activate antitumor immunity in prostate cancer. Science translational medicine 15 (694) (2023)
Zhiwen Xu, Hira Lal Goel, Christoph Burkart, Luke Burman, Yeeting E Chong, Alison G Barber, Yanyan Geng, Liting Zhai, Mengdie Wang, Ayush Kumar, Ann Menefee, Clara Polizzi, Lisa Eide, Kaitlyn Rauch, Justin Rahman, Kristina Hamel, Zachary Fogassy, Sofia Klopp-Savino, Suzanne Paz, Mingjie Zhang, Andrea Cubitt, Leslie A Nangle, Arthur M Mercurio
Inhibition of VEGF binding to neuropilin-2 enhances chemosensitivity and inhibits metastasis in triple-negative breast cancer. Science translational medicine 15 (694) (2023)
Zhiwen Xu, Hira Lal Goel, Christoph Burkart, Luke Burman, Yeeting E Chong, Alison G Barber, Yanyan Geng, Liting Zhai, Mengdie Wang, Ayush Kumar, Ann Menefee, Clara Polizzi, Lisa Eide, Kaitlyn Rauch, Justin Rahman, Kristina Hamel, Zachary Fogassy, Sofia Klopp-Savino, Suzanne Paz, Mingjie Zhang, Andrea Cubitt, Leslie A Nangle, Arthur M Mercurio
Inhibition of VEGF binding to neuropilin-2 enhances chemosensitivity and inhibits metastasis in triple-negative breast cancer. Science translational medicine 15 (694) (2023)
Mengdie Wang, Christi A Wisniewski, Choua Xiong, Peter Chhoy, Hira Lal Goel, Ayush Kumar, Julie Lihua Zhu, Rui Li, Pamela A St Louis, Lindsay M Ferreira, Hubert Pakula, Zhiwen Xu, Massimo Loda, Zhong Jiang, Michael A Brehm, Arthur M Mercurio
Therapeutic blocking of VEGF binding to neuropilin-2 diminishes PD-L1 expression to activate antitumor immunity in prostate cancer. Science translational medicine 15 (694) (2023)